In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Доклинические испытания in silico: доказательство концепции замкнутого управления сахарным диабетом 1 типа
2009-01-01
SCID: 54.1/kk97qw9m
Discuss with AI
artificial pancreasclosed-loop controlcontinuous glucose monitoringin silico preclinical trialstype 1 diabetes mellitus
Figures from the paper
Abstract (AI)
Arguably, a minimally invasive system using subcutaneous (s.c.) continuous glucose monitoring (CGM) and s.c. insulin delivery via insulin pump would be a most feasible step to closed-loop control in type 1 diabetes mellitus (T1DM). Consequently, diabetes technology is focusing on developing an artificial pancreas using control algorithms to link CGM with s.c. insulin delivery. The future development of the artificial pancreas will be greatly accelerated by employing mathematical modeling and computer simulation. Realistic computer simulation is capable of providing invaluable information about the safety and the limitations of closed-loop control algorithms, guiding clinical studies, and out-ruling ineffective control scenarios in a cost-effective manner. Thus computer simulation testing of closed-loop control algorithms is regarded as a prerequisite to clinical trials of the artificial pancreas. In this paper, we present a system for in silico testing of control algorithms that has three principal components: (1) a large cohort of n=300 simulated "subjects" (n=100 adults, 100 adolescents, and 100 children) based on real individuals' data and spanning the observed variability of key metabolic parameters in the general population of people with T1DM; (2) a simulator of CGM sensor errors representative of Freestyle Navigator™, Guardian RT, or Dexcom™ STS™, 7-day sensor; and (3) a simulator of discrete s.c. insulin delivery via OmniPod Insulin Management System or Deltec Cozmo(®) insulin pump. The system has been shown to represent adequate glucose fluctuations in T1DM observed during meal challenges, and has been accepted by the Food and Drug Administration as a substitute to animal trials in the preclinical testing of closed-loop control strategies.
Key Findings
1
A three-component in silico testing system was developed for preclinical evaluation of closed-loop artificial-pancreas control algorithms.
2
It simulates discrete subcutaneous insulin delivery using OmniPod or Deltec Cozmo insulin pumps.
3
The simulator reproduced glucose fluctuations observed during type 1 diabetes meal challenges and was accepted by the FDA as an alternative to animal trials for preclinical closed-loop testing.
4
The system simulates continuous glucose-monitoring errors characteristic of Freestyle Navigator, Guardian RT, and Dexcom STS 7-day sensors.
5
The virtual cohort includes 300 simulated people with type 1 diabetes: 100 adults, 100 adolescents, and 100 children, representing population variability in metabolic parameters.
Research Object
In silico artificial-pancreas system for closed-loop control of type 1 diabetes mellitus, comprising simulated T1DM subjects, CGM sensor-error simulation, and subcutaneous insulin-delivery simulation
Research Subject
Preclinical safety and performance assessment of closed-loop control algorithms under realistic interindividual metabolic variability, CGM sensor errors, and discrete subcutaneous insulin delivery
Publication Details
Publication Date
2009-01-01
Journal
Journal of Diabetes Science and Technology
Publisher
SAGE Publishing
ISSN
1932-2968
Cited by
872
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Cited by16
Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes2010
Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment2017
Zone Model Predictive Control: A Strategy to Minimize Hyper- and Hypoglycemic Events2010
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: The Virginia Experience2009
Continuous Glucose Monitoring Sensors: Past, Present and Future Algorithmic Challenges2016
A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator2009
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier2009
Circadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas2014
Individualized model predictive control for the artificial pancreas: In silico evaluation of closed-loop glucose control2018
Closed-loop insulin delivery for treatment of type 1 diabetes2011
Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green “Traffic” Lights Using Continuous Glucose Monitoring and Insulin Pump Data2010
In Silico Preclinical Trials: Methodology and Engineering Guide to Closed-Loop Control in Type 1 Diabetes Mellitus2009
An Insulin Infusion Advisory System Based on Autotuning Nonlinear Model-Predictive Control2011
Dynamic Insulin on Board: Incorporation of Circadian Insulin Sensitivity Variation2013
Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems2010
Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review2019